Analysis of prognostic factors for the outcome of marrow transplantation or further chemotherapy for patients with acute nonlymphocytic leukemia in first remission.
Martin S. Tallman(Memorial Sloan Kettering Cancer Center), F R Appelbaum(City Of Hope National Medical Center), E. Donnall Thomas(Centre d'Investigation Clinique Antilles Guyane), Charles A. Coltman(Wilford Hall Ambulatory Surgical Center), Joe C. Files(University of Mississippi Medical Center), K J Kopecky, D. B. Amos(Florida College), James S. Hewlett(Cleveland Clinic), S Dahlberg
Cited by 38
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3.1k